A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. - Schreiber,S.; Rutgeerts,P.; Fedorak,R.N.; Khaliq-Kareemi,M.; Kamm,M.A.; Boivin,M.; Bernstein,C.N.; Staun,M.; Thomsen,O.O.; Innes,A. (Gastroenterology, 2005)